Log in to save to my catalogue

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarizati...

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarizati...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b827f5fde746492abcab025905734a24

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

About this item

Full title

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

Publisher

England: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2018-08, Vol.37 (1), p.207-16, Article 207

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Accumulating evidence suggests that M2-polarized tumor-associated macrophages (TAMs) play an important role in cancer progression and metastasis, making M2 polarization of TAMs an ever more appealing target for therapeutic intervention. Astragaloside IV (AS-IV), a saponin component isolated from Astragali radix, has been reported to inhibit the inv...

Alternative Titles

Full title

Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b827f5fde746492abcab025905734a24

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b827f5fde746492abcab025905734a24

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-018-0878-0

How to access this item